Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mRNA
Fierce Biotech
BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal
BioNTech is buying fellow German mRNA vaccine developer CureVac in an all-stock transaction that values the acquired biotech at $1.25 billion.
James Waldron
Jun 12, 2025 8:17am
Novartis, Sarepta tipped to drive genomic therapy sales boom
May 15, 2025 12:18pm
Moderna snares key mRNA vaccine manufacturing clearance in UK
Apr 17, 2025 10:20am
AmplifyBio shutters amid tough cell and gene therapy market
Apr 7, 2025 10:38am
In high-stakes patent fight, Moderna and Pfizer trade blows
Mar 6, 2025 10:52am
Quantoom, DNA Script and EVA Pharma unite on Africa mRNA project
Feb 6, 2025 7:36am
